A detailed history of Xtx Topco LTD transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 57,100 shares of VRCA stock, worth $453,945. This represents 0.03% of its overall portfolio holdings.

Number of Shares
57,100
Previous 48,084 18.75%
Holding current value
$453,945
Previous $382,000 18.59%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025

BUY
N/A
9,016 Added 18.75%
57,100 $453,000
Q4 2024

Feb 13, 2025

SELL
N/A
-183,064 Reduced 79.2%
48,084 $382,000
Q3 2024

Nov 14, 2024

BUY
$7.95 - $7.95 $1.84 Million - $1.84 Million
231,148 New
231,148 $1.84 Million
Q1 2023

May 12, 2023

BUY
$2.88 - $8.51 $65,142 - $192,487
22,619 New
22,619 $147,000
Q2 2022

Aug 15, 2022

BUY
$1.81 - $8.93 $46,688 - $230,349
25,795 New
25,795 $50,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.